We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Advises on Marketing Requirements in EEA Nations
EMEA Advises on Marketing Requirements in EEA Nations
August 24, 2009
Drugmakers that plan to market their products in European Economic Area (EEA) nations must provide authorities in those countries with mock-ups of all product presentations at least a month before sales are scheduled to begin, according to information added to the European Medicines Agency’s (EMEA) guidance on presubmission procedures for drugs.